Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China

BACKGROUND: Autologous stem cell transplantation (ASCT) has been recommended as a standard approach for young multiple myeloma (MM) patients for decades, even in the era of novel agents. Gain of chromosome 1q21 is a common cytogenetic abnormality in MM, while its clinical prognostic value is still c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Gao, Wen, Jian, Yuan, Du, Juan, Li, Xiaozhe, Zhou, Huixing, Zhang, Zhiyao, Yang, Guangzhong, Wang, Guorong, Tian, Ying, Li, Yanchen, Wu, Yin, Fu, Weijun, Li, Juan, Chen, Wenming
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Clinical Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7643680/
https://ncbi.nlm.nih.gov/pubmed/32881351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3254
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge